Who are Capsulomics's investors?

Capsulomics's investors include Early Light Ventures, Maryland TEDCO, TEDCO, Gaingels, Riptide Ventures.

How much funding has Capsulomics raised?

Capsulomics has disclosed $2.4M raised across 1 of its 3 known rounds.

Where is Capsulomics headquartered?

Capsulomics is headquartered in Halethorpe, US.

Capsulomics

Halethorpe, US · Maryland corporation · 6 known investors

Find your way into Capsulomics

131 people in our graph share verified history with the Capsulomics team — schools, employers, funds. One of them is your warm intro.

Theodore Gresserunlockedknows William J Stevens · together at Capsulomics (overlapped)

×2knows the team · via Capsulomics

×4knows the team · via Delfi Diagnostics

×5knows the team · via Personal Genome Diagnostics

Capsulomics offers Esopredict, a DNA methylation-based risk-stratification test that predicts progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma for gastroenterologists and pathologists. The test is used as a secondary option when the company's primary TissueCypher spatialomics test cannot provide results.

AI & Machine Learning Biotech Digital Health Medical Devices

Founders & leadership

Daniel LunzExecutive

William Stevens Chief Financial Officer2021–2025William Stevens is Chief Executive Officer of Capsulomics, which develops DNA methylation-based diagnostic tests for esophageal cancer risk assessment. He previously served as Chief Financial Officer across multiple organizations over 11 years.

Stephen MeltzerNamed on SEC filing

Board

John NeiderhuberBoard director

Investors · 6

Early Light Ventureslisted by Early Light VenturesBaltimore · $100K – $500K

How we know: the VCSheet dataset · Not right? Tell us

Maryland TEDCOlisted by Maryland TEDCOUpper Marlboro · $500K – $1.5M

How we know: Maryland TEDCO's portfolio page · Not right? Tell us

TEDCOlisted by TEDCOColumbia

How we know: biospace.com · Not right? Tell us

GaingelsreportedNew York · $200K – $500K

How we know: biospace.com · Not right? Tell us

Riptide VenturesreportedBaltimore · $750K

How we know: biospace.com · Not right? Tell us

Also in the syndicate · 1

Wexford Science and Technology

Funding

SEC filings, press & company announcements

$2.4M disclosed across 1 of 3 rounds · 2019–2023

Undisclosed amountseed roundMar 2023
Gaingels, Riptide Ventures, TEDCO, Wexford Science and Technology
Source ↗
Undisclosed amountseed roundMar 2022
Source ↗

▶$2.4MraisedMar 2025 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

John NeiderhuberDirector
Daniel LunzExecutive Officer, Director
William StevensExecutive Officer
Stephen MeltzerDirector

Offering amount: $3M
Amount sold: $2.4M
First sale: Dec 2019
Incorporated: Corporation, Maryland
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Capsulomics do?: Capsulomics offers Esopredict, a DNA methylation-based risk-stratification test that predicts progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma for gastroenterologists and pathologists. The test is used as a secondary option when the company's primary TissueCypher spatialomics test cannot provide results.
Who are Capsulomics's investors?: Capsulomics's investors include Early Light Ventures, Maryland TEDCO, TEDCO, Gaingels, Riptide Ventures.
How much funding has Capsulomics raised?: Capsulomics has disclosed $2.4M raised across 1 of its 3 known rounds.
Where is Capsulomics headquartered?: Capsulomics is headquartered in Halethorpe, US.